BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Herpes Cure Advocacy - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://herpescureadvocacy.com
X-WR-CALDESC:Events for Herpes Cure Advocacy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260409T150000
DTEND;TZID=America/New_York:20260409T160000
DTSTAMP:20260204T221019Z
CREATED:20260101T022446Z
LAST-MODIFIED:20260204T221019Z
UID:6644-1775746800-1775750400@herpescureadvocacy.com
SUMMARY:Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/genital-herpes-vaccine-development-one-labs-approach-with-dr-friedman/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260305T170000
DTEND;TZID=America/New_York:20260305T180000
DTSTAMP:20260209T193938Z
CREATED:20251202T035103Z
LAST-MODIFIED:20260209T193938Z
UID:6601-1772730000-1772733600@herpescureadvocacy.com
SUMMARY:How Clinicians and Patients Talk about Herpes: Bridging the Disconnect
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/talk-with-terri-warren/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/png:https://herpescureadvocacy.com/wp-content/uploads/2024/07/aec17559-712f-43f0-9610-bca75559ba6c-e1764647445524.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T150000
DTEND;TZID=America/New_York:20260205T160000
DTSTAMP:20260128T180259Z
CREATED:20251217T035326Z
LAST-MODIFIED:20260128T180259Z
UID:6633-1770303600-1770307200@herpescureadvocacy.com
SUMMARY:Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation.
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/assembly-bio-redefining-the-treatment-of-recurrent-genital-herpes-through-long-acting-innovation/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/download.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251013T160000
DTEND;TZID=America/New_York:20251013T170000
DTSTAMP:20250919T050226Z
CREATED:20250521T013259Z
LAST-MODIFIED:20250919T050226Z
UID:5945-1760371200-1760374800@herpescureadvocacy.com
SUMMARY:Development of Better Serological Tests for HSV-1 and HSV-2 Infections with David Camerini
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/development-of-better-serological-tests-for-hsv-1-and-hsv-2-infections-with-david-camerini/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250819T150000
DTEND;TZID=America/New_York:20250819T160000
DTSTAMP:20250726T050844Z
CREATED:20250625T023309Z
LAST-MODIFIED:20250726T050844Z
UID:6052-1755615600-1755619200@herpescureadvocacy.com
SUMMARY:HSV Patient-Provider Panel
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hsv-patient-provider-panel/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2023/01/pexels-photo-8460349-e1750818768761.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250616T150000
DTEND;TZID=America/New_York:20250616T160000
DTSTAMP:20250623T024956Z
CREATED:20241216T042253Z
LAST-MODIFIED:20250623T024956Z
UID:5183-1750086000-1750089600@herpescureadvocacy.com
SUMMARY:HSV Updates - Fred Hutch
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hsv-updates-fred-hutch/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/12/marius-walter-e1734322901937.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250513T150000
DTEND;TZID=America/New_York:20250513T160000
DTSTAMP:20250514T011852Z
CREATED:20241123T200823Z
LAST-MODIFIED:20250514T011852Z
UID:4966-1747148400-1747152000@herpescureadvocacy.com
SUMMARY:Updates in Genital Herpes Epidemiology: Prevalence of Diagnosis and Antiviral Treatment Use in the United States
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hsv-epidemiology/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/1517371093081-e1732392490515.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250508T150000
DTEND;TZID=America/New_York:20250508T160000
DTSTAMP:20250418T004600Z
CREATED:20250418T004600Z
LAST-MODIFIED:20250418T004600Z
UID:5847-1746716400-1746720000@herpescureadvocacy.com
SUMMARY:Herpes Cure Pipeline 4.0 Release
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/herpes-cure-pipeline-4-0-release/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/png:https://herpescureadvocacy.com/wp-content/uploads/2025/04/Details-1-e1744937142551.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250422T150000
DTEND;TZID=America/New_York:20250422T160000
DTSTAMP:20250329T024035Z
CREATED:20241123T195947Z
LAST-MODIFIED:20250329T024035Z
UID:4963-1745334000-1745337600@herpescureadvocacy.com
SUMMARY:HSV Laboratory Testing:  Challenges and Limitations
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hsv-diagnostics/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/profile-pict-e1732502153806.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250325T150000
DTEND;TZID=America/New_York:20250325T160000
DTSTAMP:20250302T053156Z
CREATED:20250205T041145Z
LAST-MODIFIED:20250302T053156Z
UID:5504-1742914800-1742918400@herpescureadvocacy.com
SUMMARY:Dr. Betsy Harold - Disrupting the HSV:HIV Syndemic
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/advancing-science-talk-more-details-soon/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2025/01/Herold_Betsey_MD_420x504-e1740893099854.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250319T160000
DTEND;TZID=America/New_York:20250319T170000
DTSTAMP:20250302T041925Z
CREATED:20241123T195528Z
LAST-MODIFIED:20250302T041925Z
UID:4959-1742400000-1742403600@herpescureadvocacy.com
SUMMARY:The Immunocompromised Patient and Acyclovir-Resistance
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/the-immunocompromised-patient-and-acyclovir-resistance/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/293981_Fainguelernt_T_1-e1738725417918.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250226T150000
DTEND;TZID=America/New_York:20250226T160000
DTSTAMP:20250205T040938Z
CREATED:20250205T040902Z
LAST-MODIFIED:20250205T040938Z
UID:5498-1740582000-1740585600@herpescureadvocacy.com
SUMMARY:World Encephalitis Day Talk
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/world-encephalitis-day-talk/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250108T170000
DTEND;TZID=America/New_York:20250108T180000
DTSTAMP:20250112T034801Z
CREATED:20241123T193502Z
LAST-MODIFIED:20250112T034801Z
UID:4945-1736355600-1736359200@herpescureadvocacy.com
SUMMARY:Understanding the Immune Battlefields of Genital Herpes
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/understanding-the-immune-battlefields-of-genital-herpes/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/11/zhu_jia__profile.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241205T160000
DTEND;TZID=America/New_York:20241205T170000
DTSTAMP:20241121T024357Z
CREATED:20241114T034215Z
LAST-MODIFIED:20241121T024357Z
UID:4890-1733414400-1733418000@herpescureadvocacy.com
SUMMARY:Dr. Simon Delagrave: The HSV Vaccine Pipeline Needs New Ideas - a More Technical Discussion of HSV Vaccinology
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/dr-simon-delagrave-vaccines-to-prevent-and-treat-herpes-simplex-infections/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/08/thumbnail_Simon-Delagrave-photo-SD081824-e1731467294539.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241112T120000
DTEND;TZID=America/New_York:20241112T130000
DTSTAMP:20241108T031005Z
CREATED:20240819T202410Z
LAST-MODIFIED:20241108T031005Z
UID:4442-1731412800-1731416400@herpescureadvocacy.com
SUMMARY:HVTN Partnership: HSV Association with Alzheimer's Disease
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hvtn-partnership-hsv-association-with-alzheimers-disease/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/jpeg:https://herpescureadvocacy.com/wp-content/uploads/2024/06/Ruth-Itzhaki_square_md.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241015T150000
DTEND;TZID=America/New_York:20241015T160000
DTSTAMP:20241014T215844Z
CREATED:20240819T201635Z
LAST-MODIFIED:20241014T215844Z
UID:4438-1729004400-1729008000@herpescureadvocacy.com
SUMMARY:HVTN Partnership: Vaccinology of HSV
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hvtn-partnership-vaccinology-of-hsv/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/webp:https://herpescureadvocacy.com/wp-content/uploads/2024/06/4b1c8761-78fb-47cc-baa8-cfd557ef188d-e1724098757932.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240919T150000
DTEND;TZID=America/New_York:20240919T160000
DTSTAMP:20240819T202056Z
CREATED:20240819T200739Z
LAST-MODIFIED:20240819T202056Z
UID:4435-1726758000-1726761600@herpescureadvocacy.com
SUMMARY:HVTN Partnership: Presentation on the NIH/NIAID Strategic Research Plan for Herpes Simplex Virus
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/hvtn-partnership-presentation-on-the-nih-niaid-strategic-research-plan-for-herpes-simplex-virus/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/png:https://herpescureadvocacy.com/wp-content/uploads/2024/06/download.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240916T130000
DTEND;TZID=America/New_York:20240916T140000
DTSTAMP:20240917T181441Z
CREATED:20240814T174721Z
LAST-MODIFIED:20240917T181441Z
UID:4354-1726491600-1726495200@herpescureadvocacy.com
SUMMARY:Herpes Cure Pipeline: New Drugs and Vaccines on the Horizon
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/vaccines-and-the-herpes-cure-pipeline/
CATEGORIES:Conference,Guest Speaker
ORGANIZER;CN="Herpes Cure Advcocacy":MAILTO:info@herpescureadvocacy.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240718T170000
DTEND;TZID=America/Los_Angeles:20240718T180000
DTSTAMP:20240621T013344Z
CREATED:20240620T030806Z
LAST-MODIFIED:20240621T013344Z
UID:3819-1721322000-1721325600@herpescureadvocacy.com
SUMMARY:Terri Warren Talk with Q&A
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/terri-warren-talk-with-qa/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/png:https://herpescureadvocacy.com/wp-content/uploads/2024/05/Terri-Warren-Talk-718-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240305T180000
DTEND;TZID=America/New_York:20240305T190000
DTSTAMP:20240621T034511Z
CREATED:20240621T034511Z
LAST-MODIFIED:20240621T034511Z
UID:3846-1709661600-1709665200@herpescureadvocacy.com
SUMMARY:Dr. Christine Johnston GHSV1 Talk and Q&A
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/dr-christine-johnston-ghsv1-talk-and-qa/
CATEGORIES:Guest Speaker
ATTACH;FMTTYPE=image/png:https://herpescureadvocacy.com/wp-content/uploads/2024/02/health-3-2-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230920T180000
DTEND;TZID=America/New_York:20230920T190000
DTSTAMP:20240622T045123Z
CREATED:20240622T045123Z
LAST-MODIFIED:20240622T045123Z
UID:3952-1695232800-1695236400@herpescureadvocacy.com
SUMMARY:Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/highlights-from-the-herpes-cure-pipeline-3-0-w-dr-anna-wald/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230524T180000
DTEND;TZID=America/New_York:20230524T190000
DTSTAMP:20240622T042807Z
CREATED:20240622T042807Z
LAST-MODIFIED:20240622T042807Z
UID:3916-1684951200-1684954800@herpescureadvocacy.com
SUMMARY:Dr. Gary Richwald: Herpes Cure Advocacy
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/dr-gary-richwald-herpes-cure-advocacy/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230322T180000
DTEND;TZID=America/New_York:20230322T190000
DTSTAMP:20240622T042535Z
CREATED:20240622T042535Z
LAST-MODIFIED:20240622T042535Z
UID:3910-1679508000-1679511600@herpescureadvocacy.com
SUMMARY:Betsy C. Herold\, M.D.: Harold and Muriel Block Chair\, Dept. of Pediatrics
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/betsy-c-herold-m-d-harold-and-muriel-block-chair-dept-of-pediatrics/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230222T180000
DTEND;TZID=America/New_York:20230222T190000
DTSTAMP:20240622T042359Z
CREATED:20240622T042359Z
LAST-MODIFIED:20240622T042359Z
UID:3907-1677088800-1677092400@herpescureadvocacy.com
SUMMARY:Dr. Keith Jerome: Fred Hutch Cancer Center
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/dr-keith-jerome-fred-hutch-cancer-center/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230201T180000
DTEND;TZID=America/New_York:20230201T190000
DTSTAMP:20240622T042250Z
CREATED:20240622T042250Z
LAST-MODIFIED:20240622T042250Z
UID:3904-1675274400-1675278000@herpescureadvocacy.com
SUMMARY:Dr. TJ Cradick: Excision Biotherapeutics
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/dr-tj-cradick-excision-biotherapeutics/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230125T170000
DTEND;TZID=America/New_York:20230125T180000
DTSTAMP:20240622T042121Z
CREATED:20240622T042121Z
LAST-MODIFIED:20240622T042121Z
UID:3902-1674666000-1674669600@herpescureadvocacy.com
SUMMARY:Pritelivir: Latest updates from Aicuris
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/pritelivir-latest-updates-from-aicuris/
CATEGORIES:Guest Speaker
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230111T180000
DTEND;TZID=America/New_York:20230111T190000
DTSTAMP:20240622T041827Z
CREATED:20240622T041827Z
LAST-MODIFIED:20240622T041827Z
UID:3899-1673460000-1673463600@herpescureadvocacy.com
SUMMARY:UPenn/BioNTech Clinical Trials: Latest updates and Q&A with Dr Harvey Friedman
DESCRIPTION:Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccine design and ongoing studies in his lab that examine whether a vaccine intended to prevent genital herpes caused by HSV-2 may also be effective againstContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"
URL:https://herpescureadvocacy.com/event/upenn-biontech-clinical-trials-latest-updates-and-qa-with-dr-harvey-friedman/
CATEGORIES:Guest Speaker
END:VEVENT
END:VCALENDAR